DETECTION OF P16/KI-67 MARKERS IN THE DETECTION OF CERVICAL INTRAEPITHELIAL NEOPLASIA
-
Published:2023
Issue:4
Volume:95
Page:24-31
-
ISSN:1728-2748
-
Container-title:Bulletin of Taras Shevchenko National University of Kyiv. Series: Biology
-
language:
-
Short-container-title:BTSNUKSB
Author:
, Novokhatska MarynaORCID, Kalmukova OlesiaORCID, , Skrypnyk NataliiaORCID, , Nebyltsova Oksana,
Abstract
B a c k g r o u n d . In recent years, Ukraine has experienced an unfavorable epidemiological situation concerning sexually transmitted diseases. One rapidly spreading infection is genital human papillomavirus (HPV). Convincing research has identified human papillomavirus (HPV) as a significant factor in the development of malignant transformations in the cervix. The study of the molecular pathogenesis associated with HPV-related neoplasms has led to the discovery of biomarkers aiding in the diagnosis of High-grade Squamous Intraepithelial Lesion (HSIL) of the cervix. Including the biomarkers p16/Ki-67 in the investigation enhances sensitivity in detecting HSIL in women. Additionally, it is pertinent to further analyze the effectiveness of using an additional semi-quantitative scale to assess the results of immunocytochemical detection of p16/Ki-67. M e t h o d s . The research was conducted on biological material from cervical smears using liquid-based cytology. Techniques included Papanicolaou staining, HPV detection, and immunocytochemical staining against p16/Ki-67. The sample comprised 90 women divided into three age groups, each categorized based on criteria such as HPV presence/absence, Bethesda classification of dysplasia, and negative/positive p16/Ki-67 results. Intensity of staining was further scored on a scale in the corresponding location of positive reactions in the nucleus or cytoplasm. R e s u l t s . The study revealed that immunocytochemical markers p16 and Ki-67 identified women with intraepithelial lesions, especially in cases with positive HPV results and no dysplastic changes in the Pap test. The intensity of immunocytochemical staining for p16 and Ki-67 varied directly with the detected degree of dysplasia. C o n c l u s i o n s . A direct correlation was observed between the severity of dysplasia established by Bethesda classification and the intensity of immunocytochemical staining for p16 and Ki-67. These findings provide an opportunity for further exploration of staining intensity in the presence of immunocytochemical markers p16 and Ki-67 for their potential use in the comprehensive interpretation of Pap test results and the precise identification of dysplasia in ambiguous diagnostic samples.
Publisher
Taras Shevchenko National University of Kyiv
Reference37 articles.
1. Celewicz, A., Celewicz, M., Wężowska, M., Chudecka-Głaz, A., Menkiszak, J., & Urasińska, E. (2018). Clinical efficacy of p16/Ki-67 dual-stained cervical cytology in secondary prevention of cervical cancer. Polish Journal of Pathology, 69(1), 42-47. https://doi.org/10.5114/pjp.2018.75335 2. Cuschieri, K., & Wentzensen, N. (2008). Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia. Cancer Epidemiol Biomarkers Prev., 17(10), 2536-2545. https://doi.org/10.1158/1055-9965.epi-08-0306 3. Dovnik, A., & Repše Fokter, A. (2023). The Role of p16/Ki67 Dual Staining in Cervical Cancer Screening. Current Issues in Molecular Biology, 45(10), 8476-8491. https://doi.org/10.3390/cimb45100534 4. El‐Zein, M., Gotlieb, W., Gilbert, L., Hemmings, R., Behr, M. A., & Franco, E. L. (2021). Dual staining for p16/Ki‐67 to detect high‐grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study. International Journal of Cancer, 148(2), 492-501. https://doi.org/10.1002/ijc.33250 5. Fedorenko, Z. P., Sumkin, O. V., Zub, V. O., Horokh, E. L., Gulak, L. O., Ryzhov, A. Yu., & Yefimenko, O. V. (2023). Bulletin of the National Cancer Registry of Ukraine, 24, 53. https://www.ncru.inf.ua/publications/BULL_24/ PDF/66-shm.pdf [in Ukrainian].
|
|